Diagnosis and Pathogenesis of Multiple Sclerosis

Displaying 1 - 11 of 11CSV
Simani, L., Tozlu, C., Lee, S., Dworkin, J., Ratzan, A. S., Buyukturkoglu, K., Onomichi, K., Mata, J., Riley, C. S., & Leavitt, V. M. (2025). Longitudinal investigation of neuroimaging changes related to memory decline in multiple sclerosis: Testing a mechanistic model. Multiple Sclerosis Journal, 31(2), 207–217. https://doi.org/10.1177/13524585241303491
Publication Date
Deffner, M., Schneider-Hohendorf, T., Schulte-Mecklenbeck, A., Falk, S., Lu, I.-N., Ostkamp, P., Müller-Miny, L., Schumann, E. M., Goelz, S., Cahir-McFarland, E., Thakur, K. T., De Jager, P. L., Klotz, L., Meyer zu Hörste, G., Gross, C. C., Wiendl, H., Grauer, O. M., & Schwab, N. (2024). Chemokine-mediated cell migration into the central nervous system in progressive multifocal leukoencephalopathy. Cell Reports Medicine, 5(7), 101622. https://doi.org/10.1016/j.xcrm.2024.101622
Publication Date
Nishiyama, S., Seok, J. M., Wright, A. E., Lotan, I., Mikami, T., Drosu, N. C., Bobrowski-Khoury, N., Anderson, M. R., Bilodeau, P. A., Schindler, P., Paul, F., Aoki, M., Yeaman, M. R., Levy, M., Behne, J. M., Behne, M. K., Bennett, J. L., Blaschke, T. F., … Chitnis, T. (2024). Anti-aquaporin-4 immune complex stimulates complement-dependent Th17 cytokine release in neuromyelitis optica spectrum disorders. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-53661-5
Publication Date
Radzik, A. M., Amezcua, L., Anderson, A., Gilmore, S., Ahmad, S., Brandstadter, R., Fabian, M. T., Graham, E. L., Hodgkinson, S., Horton, L., Jacobs, D. A., Katz Sand, I. B., Kohli, A., Levine, L., McLemore, M., Okai, A. F., Patel, J., Poole, S., Riley, C., … Bove, R. (2024). Disparities by Race in Pregnancy Care and Clinical Outcomes in Women With Multiple Sclerosis. Neurology, 102(4). https://doi.org/10.1212/wnl.0000000000208100
Publication Date
Riley, C., Venkatesh, S., Dhand, A., Doshi, N., Kavak, K., Levit, E., Perrone, C., Weinstock-Guttman, B., Longbrake, E., De Jager, P., & Xia, Z. (2024). Impact of the COVID-19 Pandemic on the Personal Networks and Neurological Outcomes of People With Multiple Sclerosis: Cross-Sectional and Longitudinal Case-Control Study. JMIR Public Health and Surveillance, 10, e45429. https://doi.org/10.2196/45429
Publication Date
Williams, M. J., Amezcua, L., Chinea, A., Cohan, S., Okai, A., Okuda, D. T., Vargas, W., Belviso, N., Božin, I., Jiang, X., Lewin, J. B., Lyons, J., Shen, C., England, S. M., & Grimes, N. (2023). Real-World Safety and Effectiveness After 5 Years of Dimethyl Fumarate Treatment in Black and Hispanic Patients with Multiple Sclerosis in ESTEEM. Neurology and Therapy, 12(5), 1669–1682. https://doi.org/10.1007/s40120-023-00517-1
Publication Date
Anderson, A., Rowles, W., Poole, S., Balan, A., Bevan, C., Brandstadter, R., Ciplea, A. I., Cooper, J., Fabian, M., Hale, T. W., Jacobs, D., Kakara, M., Krysko, K. M., Longbrake, E. E., Marcus, J., Repovic, P., Riley, C. S., Romeo, A. R., Rutatangwa, A., … Bove, R. (2023). Anti‐CD20 monoclonal antibody therapy in postpartum women with neurological conditions. Annals of Clinical and Translational Neurology, 10(11), 2053–2064. Portico. https://doi.org/10.1002/acn3.51893
Publication Date
Amezcua, L., Mao-Draayer, Y., Vargas, W. S., Farber, R., Schaefer, S., Branco, F., England, S. M., Belviso, N., Lewin, J. B., Mendoza, J. P., & Shankar, S. L. (2023). Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies. Neurology and Therapy, 12(3), 883–897. https://doi.org/10.1007/s40120-023-00475-8
Publication Date
Petracca, M., Palladino, R., Droby, A., Kurz, D., Graziano, N., Wang, K., Riley, C., Howard, J., Klineova, S., Lublin, F., & Inglese, M. (2023). Disability outcomes in early-stage African American and White people with multiple sclerosis. Multiple Sclerosis and Related Disorders, 69, 104413. https://doi.org/10.1016/j.msard.2022.104413
Publication Date
Landau, H. J., Orlando, E., Rodriguez, E. S., Applebaum, A., Mitchell, H.-R., Peled, J. U., Khan, N., Funnell, T., Chung, D., Scordo, M., Shah, G. L., LeStrange, N. J., Hambright, K. A., McElrath, C. M., Cazeau, N., Devlin, S. M., Perales, M.-A., van den Brink, M. R. M., & Giralt, S. A. (2022). Pilot Trial of Homebound Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy, 28(12), 832.e1-832.e7. https://doi.org/10.1016/j.jtct.2022.09.014
Publication Date